Skip To Main Content
Karen Macdonald on Muck Rack

Karen Macdonald

Montreal
As seen in: Wiley Online Library, PLOS ONE, CFRE-TV (Regina, SK), Global News, JAMA (The Journal of the American Medical Association), The Portland Press Herald, Arizona Daily Star, Global TV, Morning Sentinel, Mondaq and
News Director and Station Manager at Global Montreal. Originally from Quebec City where I was the Publisher of the Quebec Chronicle-Telegraph for 14 years.

Get in touch with Karen

Contact Karen, search articles and posts on X, monitor coverage, and track replies from one place.

Learn more about Muck Rack

Actions

Share this page

Articles

EE250 A UNIQUE PATTERN OF AVERAGE SALES PRICE EROSION OF PEGFILGRASTIM FOLLOWING BIOSIMILAR ENTRY INTO THE US MARKET

|
By Brian L. Erstad, Karen Macdonald
| Value in Health Journal Verified
To quantify the erosion in the Average Sales Price (ASP) for pegfilgrastim and its biosimilars covered under Medicare Part B from 2011Q2 to 2024Q4.
Open in Who Shared Issue with article?

EE14 COST-EFFICIENCY AND EXPANDED-ACCESS OF KIRSTY/MERILOG VS NOVOLOG IN DIABETES MELLITUS

|
By Karen Macdonald, R. Ken Coit College
| Value in Health Journal Verified
In 2025, Kirsty and Merilog were approved by the FDA as biosimilars to Novolog (insulin aspart) in adult and pediatric diabetic patients. This study assessed the cost-efficiency and expanded-access of conversion to these biosimilars from the reference from the US payer perspective.
Open in Who Shared Issue with article?

To test or not to test? Study protocol for a best-worst scaling to understand decision-making and preferences for genetic testing in moderate-risk individuals

|
By Carina Oedingen, Karen Macdonald, Julien Marcadier, Nicolle Hua
| PLOS ONE
Loading metrics Open Access Study Protocol Citation: Oedingen C, Hua N, MacDonald KV, Marcadier J, Perrier R, Tuer L, et al. (2025) To test or not to test? Study protocol for a best-worst scaling to understand decision-making and preferences for genetic testing in moderate-risk individuals. PLoS One 20(12): e0339696.
Open in Who Shared Issue with article?
See all 76 licensed articles (82 Total)